Page 89 - Lipids News Today

Scientists were interested in further investigating the defense mechanism of earthworms in an effort to discover therapeutic solutions against SARS-CoV-2.

With an essential role established for SGLT2 inhibitors for patients with progressive renal dysfunction or heart failure, researchers discuss how best to use these agents in those with type 2 diabetes.

Sufficient levels of iron in the blood might prevent about 1 in 10 diagnoses of coronary heart disease and reduce mortality risk. The good news” lots of healthy foods have iron in abundance.

Observational studies suggested patients with COVID-19 taking statins have better outcomes. A new review looks at trials underway assessing lipid-modifying agents to treat or prevent COVID-19.

Greater increases in fasting ghrelin associated with improved metabolic benefits seen with plant-enhanced Mediterranean diet. But one commentator calls the findings simply hypothesis-generating.

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival.

Maja Marcus and colleagues use nationally-representative surveys conducted between 2009 and 2018 to investigate the unmet need for hypercholesterolemia care in 35 low- and middle-income countries.

Certain blood pressure–lowering agents, especially diuretics, may reduce Alzheimers pathology and other brain disease processes, new research suggests.

In recent years, there has been some evidence that dietary interventions can help to slow the growth of tumors.

Results of a new study provide another reason to get patients to quit the nicotine habit and control other vascular risk factors.